Cargando…

CD73 acts as a prognostic biomarker and promotes progression and immune escape in pancreatic cancer

CD73 is a glycosylphosphatidylinositol (GPI)‐anchored protein that attenuates tumour immunity via cooperating with CD39 to generate immunosuppressive adenosine. Therefore, CD73 blockade has been incorporated into clinical trials for cancers based on preclinical efficacy. However, the biological role...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Qiangda, Pu, Ning, Yin, Hanlin, Zhang, Jicheng, Zhao, Guochao, Lou, Wenhui, Wu, Wenchuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7412695/ https://www.ncbi.nlm.nih.gov/pubmed/32643277 http://dx.doi.org/10.1111/jcmm.15500

Ejemplares similares

Chemokine C‐C motif ligand 21 synergized with programmed death‐ligand 1 blockade restrains tumor growth
por: Chen, Qiangda, et al.
Publicado: (2021)

Tumor Microenvironment Responsive CD8(+) T Cells and Myeloid‐Derived Suppressor Cells to Trigger CD73 Inhibitor AB680‐Based Synergistic Therapy for Pancreatic Cancer
por: Chen, Qiangda, et al.
Publicado: (2023)

Gut-derived lipopolysaccharide remodels tumoral microenvironment and synergizes with PD-L1 checkpoint blockade via TLR4/MyD88/AKT/NF-κB pathway in pancreatic cancer
por: Yin, Hanlin, et al.
Publicado: (2021)

Tumor‐associated N1 and N2 neutrophils predict prognosis in patients with resected pancreatic ductal adenocarcinoma: A preliminary study
por: Yin, Hanlin, et al.
Publicado: (2022)

Circulating cytokines allow for identification of malignant intraductal papillary mucinous neoplasms of the pancreas
por: Pu, Ning, et al.
Publicado: (2022)

Prognostic value of tumor-associated N1/N2 neutrophil plasticity in patients following radical resection of pancreas ductal adenocarcinoma
por: Chen, Qiangda, et al.
Publicado: (2022)

CD25 and TGF-β blockade based on predictive integrated immune ratio inhibits tumor growth in pancreatic cancer
por: Pu, Ning, et al.
Publicado: (2018)

Survival outcomes of pancreaticoduodenectomy versus extended pancreaticoduodenectomy procedure for pancreatic head carcinoma: a propensity score matching study
por: Pu, Ning, et al.
Publicado: (2020)

Comprehensive Diagnostic Nomogram for Predicting Clinically Relevant Postoperative Pancreatic Fistula After Pancreatoduodenectomy
por: Li, Bo, et al.
Publicado: (2021)

The effect of primary site, functional status and treatment modality on survival in gastroenteropancreatic neuroendocrine neoplasms with synchronous liver metastasis: a US population-based study
por: Pu, Ning, et al.
Publicado: (2021)

Comparison of prognostic prediction between nomogram based on lymph node ratio and AJCC 8th staging system for patients with resected pancreatic head carcinoma: a SEER analysis
por: Pu, Ning, et al.
Publicado: (2018)

Independent effect of postoperative neutrophil-to-lymphocyte ratio on the survival of pancreatic ductal adenocarcinoma with open distal pancreatosplenectomy and its nomogram-based prediction
por: Pu, Ning, et al.
Publicado: (2019)

The evolution and heterogeneity of neutrophils in cancers: origins, subsets, functions, orchestrations and clinical applications
por: Liu, Siyao, et al.
Publicado: (2023)

Survival benefit and impact of adjuvant chemotherapy following systemic neoadjuvant chemotherapy in patients with resected pancreas ductal adenocarcinoma: a retrospective cohort study
por: Pu, Ning, et al.
Publicado: (2023)

The distinct role of CD73 in the progression of pancreatic cancer
por: Zhou, Liangjing, et al.
Publicado: (2019)

Alkaline Phosphatase-To-Albumin Ratio as a Prognostic Indicator in Pancreatic Ductal Adenocarcinoma after Curative Resection
por: Pu, Ning, et al.
Publicado: (2017)

PYCR1: A Potential Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma
por: Wang, Huanyu, et al.
Publicado: (2022)

A Novel Anti-CD73 Antibody That Selectively Inhibits Membrane CD73 Shows Antitumor Activity and Induces Tumor Immune Escape
por: Kellner, Markus, et al.
Publicado: (2022)

Radiofrequency ablation in combination with an mTOR inhibitor restrains pancreatic cancer growth induced by intrinsic HSP70
por: Gao, Shanshan, et al.
Publicado: (2020)

Integrative analyses identify CD73 as a prognostic biomarker and immunotherapeutic target in intrahepatic cholangiocarcinoma
por: Sun, Bao-Ye, et al.
Publicado: (2023)

CD73: A Promising Biomarker in Cancer Patients
por: Turiello, Roberta, et al.
Publicado: (2020)

Neutralizing TGF-β promotes anti-tumor immunity of dendritic cells against pancreatic cancer by regulating T lymphocytes
por: Pu, Ning, et al.
Publicado: (2018)

The Effects of CD73 on Gastrointestinal Cancer Progression and Treatment
por: Sun, Pengcheng, et al.
Publicado: (2022)

Prognostic Effect of Age in Resected Pancreatic Cancer Patients: A Propensity Score Matching Analysis
por: Xu, Yaolin, et al.
Publicado: (2022)

Exploring CD39 and CD73 Expression as Potential Biomarkers in Prostate Cancer
por: Gardani, Carla Fernanda Furtado, et al.
Publicado: (2023)

Prognostic impact of CD73 expression and its relationship to PD-L1 in patients with radically treated pancreatic cancer
por: Tahkola, Kyösti, et al.
Publicado: (2020)

The latest exploration of staging and prognostic classification for pancreatic neuroendocrine tumors: a large population-based study
por: Gao, Shanshan, et al.
Publicado: (2018)

Impact of CRISPR/Cas9-Mediated CD73 Knockout in Pancreatic Cancer
por: Zhang, Jinping, et al.
Publicado: (2023)

A meta-analysis of the prognostic impact of tissue golgi protein 73 (tGP73) in hepatocellular carcinoma
por: Yu, Wei-Ming, et al.
Publicado: (2023)

CD73 Overexpression Promotes Progression and Recurrence of Papillary Thyroid Carcinoma
por: Jeong, Young Mun, et al.
Publicado: (2020)

Genetic landscape of prognostic value in pancreas ductal adenocarcinoma microenvironment—reply
por: Pu, Ning, et al.
Publicado: (2020)

The Roles of CD73 in Cancer
por: Gao, Zhao-wei, et al.
Publicado: (2014)

Prognostic value of CD73 expression in resected colorectal cancer liver metastasis
por: Messaoudi, Nouredin, et al.
Publicado: (2020)

Prognostic significance and immune correlates of CD73 expression in renal cell carcinoma
por: Tripathi, Abhishek, et al.
Publicado: (2020)

The soluble form of CD160 acts as a tumor mediator of immune escape in melanoma
por: Gauci, Marie-Léa, et al.
Publicado: (2022)

Soluble CD73 as biomarker in patients with metastatic melanoma patients treated with nivolumab
por: Morello, Silvana, et al.
Publicado: (2017)

Prospective isolation of human fibroadipogenic progenitors with CD73
por: Goloviznina, Natalya A., et al.
Publicado: (2020)

CD73 Promotes Tumor Progression in Patients with Esophageal Squamous Cell Carcinoma
por: Chen, Yen-Hao, et al.
Publicado: (2021)

CD73 Severed as a Potential Prognostic Marker and Promote Lung Cancer Cells Migration via Enhancing EMT Progression
por: Gao, Zhao-wei, et al.
Publicado: (2021)

Evaluation of circulating tumor DNA as a prognostic biomarker for metastatic pancreatic adenocarcinoma
por: Guan, Shasha, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_r7mhtogvtqh3ei98aeeis7vbol